Garry G. Graham
Department of Pharmacology & Toxicology
St Vincents Clinical School
University of New South Wales
Sydney
Australia
Name/email consistency: high
- Clinical pharmacokinetics of metformin. Graham, G.G., Punt, J., Arora, M., Day, R.O., Doogue, M.P., Duong, J.K., Furlong, T.J., Greenfield, J.R., Greenup, L.C., Kirkpatrick, C.M., Ray, J.E., Timmins, P., Williams, K.M. Clin. Pharmacokinet (2011)
- FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? Graham, G.G., Day, R.O., Graudins, A., Mohamudally, A. Inflammopharmacology (2010)
- Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes. Graham, G.G., Whitehouse, M.W., Bushell, G.R. Inflammopharmacology (2008)
- Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol). Graham, G.G., Graham, R.I., Day, R.O. Curr. Pharm. Des. (2002)
- The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase. Graham, G.G., Kettle, A.J. Biochem. Pharmacol. (1998)